Intermolecular insights into allosteric inhibition of histone lysine-specific demethylase 1
Histone lysine-specific demethylase 1 (LSD1) has become a potential anticancer target for the novel drug discovery. Recent reports have shown that SP2509 and its derivatives strongly inhibit LSD1 as allosteric inhibitors. However, the binding mechanism of these allosteric inhibitors in the allosteri...
Saved in:
Published in | Biochimica et biophysica acta. General subjects Vol. 1865; no. 11; p. 129990 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Elsevier B.V
01.11.2021
|
Subjects | |
Online Access | Get full text |
ISSN | 0304-4165 1872-8006 1872-8006 |
DOI | 10.1016/j.bbagen.2021.129990 |
Cover
Abstract | Histone lysine-specific demethylase 1 (LSD1) has become a potential anticancer target for the novel drug discovery. Recent reports have shown that SP2509 and its derivatives strongly inhibit LSD1 as allosteric inhibitors. However, the binding mechanism of these allosteric inhibitors in the allosteric site of LSD1 is not known yet.
The stability and binding mechanism of allosteric inhibitors in the binding site of LSD1 were evaluated by molecular docking, ligand-based pharmacophore, molecular dynamics (MD) simulations, molecular mechanics generalized born surface area (MM/GBSA) analysis, quantum mechanics/molecular mechanics (QM/MM) calculation and Hirshfeld surface analysis.
The conformational geometry and the intermolecular interactions of allosteric inhibitors showed high binding affinity towards allosteric site of LSD1 with the neighboring amino acids (Gly358, Cys360, Leu362, Asp375 and Glu379). Meanwhile, MD simulations and MM/GBSA analysis were performed on selected allosteric inhibitors in complex with LSD1 protein, which confirmed the high stability and binding affinity of these inhibitors in the allosteric site of LSD1.
The simulation results revealed the crucial factors accounting for allosteric inhibitors of LSD1, including different protein–ligand interactions, the positions and conformations of key residues, and the ligands flexibilities. Meanwhile, a halogen bond interaction between chlorine atom of ligand and key residues Trp531 and His532 was recurrent in our analysis confirming its importance.
Overall, our research analyzed in depth the binding modes of allosteric inhibitors with LSD1 and could provide useful information for the design of novel allosteric inhibitors.
[Display omitted]
•The stability and binding mechanism of allosteric inhibitors in the binding site of LSD1 were estimated by molecular docking and pharmacophore.•Based on the QM/MM optimization, intermolecular interactions of selected complexes were analyzed by hirshfeld surfaces.•An interaction model inside the LSD1 allosteric site was proposed to provide guidance for designing LSD1 inhibitors. |
---|---|
AbstractList | Histone lysine-specific demethylase 1 (LSD1) has become a potential anticancer target for the novel drug discovery. Recent reports have shown that SP2509 and its derivatives strongly inhibit LSD1 as allosteric inhibitors. However, the binding mechanism of these allosteric inhibitors in the allosteric site of LSD1 is not known yet.BACKGROUNDHistone lysine-specific demethylase 1 (LSD1) has become a potential anticancer target for the novel drug discovery. Recent reports have shown that SP2509 and its derivatives strongly inhibit LSD1 as allosteric inhibitors. However, the binding mechanism of these allosteric inhibitors in the allosteric site of LSD1 is not known yet.The stability and binding mechanism of allosteric inhibitors in the binding site of LSD1 were evaluated by molecular docking, ligand-based pharmacophore, molecular dynamics (MD) simulations, molecular mechanics generalized born surface area (MM/GBSA) analysis, quantum mechanics/molecular mechanics (QM/MM) calculation and Hirshfeld surface analysis.METHODSThe stability and binding mechanism of allosteric inhibitors in the binding site of LSD1 were evaluated by molecular docking, ligand-based pharmacophore, molecular dynamics (MD) simulations, molecular mechanics generalized born surface area (MM/GBSA) analysis, quantum mechanics/molecular mechanics (QM/MM) calculation and Hirshfeld surface analysis.The conformational geometry and the intermolecular interactions of allosteric inhibitors showed high binding affinity towards allosteric site of LSD1 with the neighboring amino acids (Gly358, Cys360, Leu362, Asp375 and Glu379). Meanwhile, MD simulations and MM/GBSA analysis were performed on selected allosteric inhibitors in complex with LSD1 protein, which confirmed the high stability and binding affinity of these inhibitors in the allosteric site of LSD1.RESULTSThe conformational geometry and the intermolecular interactions of allosteric inhibitors showed high binding affinity towards allosteric site of LSD1 with the neighboring amino acids (Gly358, Cys360, Leu362, Asp375 and Glu379). Meanwhile, MD simulations and MM/GBSA analysis were performed on selected allosteric inhibitors in complex with LSD1 protein, which confirmed the high stability and binding affinity of these inhibitors in the allosteric site of LSD1.The simulation results revealed the crucial factors accounting for allosteric inhibitors of LSD1, including different protein-ligand interactions, the positions and conformations of key residues, and the ligands flexibilities. Meanwhile, a halogen bond interaction between chlorine atom of ligand and key residues Trp531 and His532 was recurrent in our analysis confirming its importance.CONCLUSIONThe simulation results revealed the crucial factors accounting for allosteric inhibitors of LSD1, including different protein-ligand interactions, the positions and conformations of key residues, and the ligands flexibilities. Meanwhile, a halogen bond interaction between chlorine atom of ligand and key residues Trp531 and His532 was recurrent in our analysis confirming its importance.Overall, our research analyzed in depth the binding modes of allosteric inhibitors with LSD1 and could provide useful information for the design of novel allosteric inhibitors.GENERAL SIGNIFICANCEOverall, our research analyzed in depth the binding modes of allosteric inhibitors with LSD1 and could provide useful information for the design of novel allosteric inhibitors. Histone lysine-specific demethylase 1 (LSD1) has become a potential anticancer target for the novel drug discovery. Recent reports have shown that SP2509 and its derivatives strongly inhibit LSD1 as allosteric inhibitors. However, the binding mechanism of these allosteric inhibitors in the allosteric site of LSD1 is not known yet.The stability and binding mechanism of allosteric inhibitors in the binding site of LSD1 were evaluated by molecular docking, ligand-based pharmacophore, molecular dynamics (MD) simulations, molecular mechanics generalized born surface area (MM/GBSA) analysis, quantum mechanics/molecular mechanics (QM/MM) calculation and Hirshfeld surface analysis.The conformational geometry and the intermolecular interactions of allosteric inhibitors showed high binding affinity towards allosteric site of LSD1 with the neighboring amino acids (Gly358, Cys360, Leu362, Asp375 and Glu379). Meanwhile, MD simulations and MM/GBSA analysis were performed on selected allosteric inhibitors in complex with LSD1 protein, which confirmed the high stability and binding affinity of these inhibitors in the allosteric site of LSD1.The simulation results revealed the crucial factors accounting for allosteric inhibitors of LSD1, including different protein–ligand interactions, the positions and conformations of key residues, and the ligands flexibilities. Meanwhile, a halogen bond interaction between chlorine atom of ligand and key residues Trp531 and His532 was recurrent in our analysis confirming its importance.Overall, our research analyzed in depth the binding modes of allosteric inhibitors with LSD1 and could provide useful information for the design of novel allosteric inhibitors. Histone lysine-specific demethylase 1 (LSD1) has become a potential anticancer target for the novel drug discovery. Recent reports have shown that SP2509 and its derivatives strongly inhibit LSD1 as allosteric inhibitors. However, the binding mechanism of these allosteric inhibitors in the allosteric site of LSD1 is not known yet. The stability and binding mechanism of allosteric inhibitors in the binding site of LSD1 were evaluated by molecular docking, ligand-based pharmacophore, molecular dynamics (MD) simulations, molecular mechanics generalized born surface area (MM/GBSA) analysis, quantum mechanics/molecular mechanics (QM/MM) calculation and Hirshfeld surface analysis. The conformational geometry and the intermolecular interactions of allosteric inhibitors showed high binding affinity towards allosteric site of LSD1 with the neighboring amino acids (Gly358, Cys360, Leu362, Asp375 and Glu379). Meanwhile, MD simulations and MM/GBSA analysis were performed on selected allosteric inhibitors in complex with LSD1 protein, which confirmed the high stability and binding affinity of these inhibitors in the allosteric site of LSD1. The simulation results revealed the crucial factors accounting for allosteric inhibitors of LSD1, including different protein–ligand interactions, the positions and conformations of key residues, and the ligands flexibilities. Meanwhile, a halogen bond interaction between chlorine atom of ligand and key residues Trp531 and His532 was recurrent in our analysis confirming its importance. Overall, our research analyzed in depth the binding modes of allosteric inhibitors with LSD1 and could provide useful information for the design of novel allosteric inhibitors. [Display omitted] •The stability and binding mechanism of allosteric inhibitors in the binding site of LSD1 were estimated by molecular docking and pharmacophore.•Based on the QM/MM optimization, intermolecular interactions of selected complexes were analyzed by hirshfeld surfaces.•An interaction model inside the LSD1 allosteric site was proposed to provide guidance for designing LSD1 inhibitors. |
ArticleNumber | 129990 |
Author | Sun, Yixiang Wang, Jian Zhao, Dongmei Wang, Hanxun Zhang, Xiangyu Zhang, Ziheng |
Author_xml | – sequence: 1 givenname: Xiangyu surname: Zhang fullname: Zhang, Xiangyu organization: Key Laboratory of Structure-Based Drug Design & Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, Liaoning, PR China – sequence: 2 givenname: Yixiang surname: Sun fullname: Sun, Yixiang organization: Key Laboratory of Structure-Based Drug Design & Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, Liaoning, PR China – sequence: 3 givenname: Ziheng surname: Zhang fullname: Zhang, Ziheng organization: Key Laboratory of Structure-Based Drug Design & Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, Liaoning, PR China – sequence: 4 givenname: Hanxun surname: Wang fullname: Wang, Hanxun organization: Key Laboratory of Structure-Based Drug Design & Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, Liaoning, PR China – sequence: 5 givenname: Jian surname: Wang fullname: Wang, Jian email: jianwang@syphu.edu.cn organization: Key Laboratory of Structure-Based Drug Design & Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, Liaoning, PR China – sequence: 6 givenname: Dongmei surname: Zhao fullname: Zhao, Dongmei email: dongmeiz-67@163.com organization: Key Laboratory of Structure-Based Drug Design & Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, Liaoning, PR China |
BookMark | eNqNkDFvFDEQhS0UJC6Bf0CxJc0etndtrymQUERIpEhpQkVh-bzj3Jx89mH7kO7f49NSUSSZZmY07z2NvktyEVMEQj4yumaUyc-79WZjnyCuOeVszbjWmr4hKzYp3k-UyguyogMd-5FJ8Y5clrKjrYQWK_LrLlbI-xTAHYPNHcaCT9ta2lBTZ0NIpd3RtX2LG6yYYpd8t8VS2w9dOBWM0JcDOPRNNcMe6vYUbIGOvSdvvQ0FPvzrV-TnzffH69v-_uHH3fW3-94NitdeUj96urEzZw6UE6OcFUgxOy28mKVTHlj7VYwaLDALapJ00qAHrrRXVg5X5NOSe8jp9xFKNXssDkKwEdKxGC4HOUo-6VdIhWSjpoM6S78sUpdTKRm8cVjtGUDNFoNh1Jzhm51Z4JszfLPAb-bxP_Mh497m00u2r4sNGq4_CNkUhxAdzJjBVTMnfD7gL1yMo4g |
CitedBy_id | crossref_primary_10_1016_j_ejmech_2022_114523 crossref_primary_10_1016_j_phrs_2021_105958 crossref_primary_10_1080_17460441_2022_2114451 crossref_primary_10_1021_acs_jpcb_3c06900 crossref_primary_10_1002_mco2_269 crossref_primary_10_1016_j_tips_2025_01_006 crossref_primary_10_1016_j_ejmech_2022_114714 crossref_primary_10_1016_j_freeradbiomed_2024_04_220 |
Cites_doi | 10.1007/s11255-015-0915-2 10.1021/acs.jmedchem.7b00462 10.1038/s41585-019-0154-x 10.1016/j.molstruc.2020.128780 10.3390/molecules23071538 10.1016/j.canlet.2019.03.052 10.1038/aps.2011.145 10.1021/acs.jmedchem.5b01361 10.1016/j.ejmech.2020.112235 10.1021/jm3002845 10.1371/journal.pone.0235705 10.1021/acs.jmedchem.6b01018 10.1021/acs.jmedchem.5b01209 10.1021/acs.jmedchem.5b00037 10.1021/acsmedchemlett.9b00604 10.1038/nmeth.4067 10.1021/acs.jmedchem.6b01019 10.1039/C9SC02834J 10.1016/j.cell.2004.12.012 10.1038/leu.2014.119 10.1128/JVI.00974-20 10.1039/C9CP04353E 10.1021/jm400870h 10.1021/acsomega.8b00815 10.1021/jp408166m 10.1021/jm201048w 10.1038/s41375-019-0659-6 10.1021/bi300068r 10.1073/pnas.1719168115 10.3389/fonc.2018.00255 10.1186/s13045-019-0811-9 10.1002/anie.201608711 10.1016/j.ejmech.2012.08.010 10.1517/13543776.2016.1165209 10.1016/j.ejmech.2018.11.035 10.1021/ct900587b 10.1177/1758835920937428 10.1021/jm401002r 10.1002/cmdc.201400016 10.1016/j.bmcl.2015.06.054 10.1002/med.21350 10.1016/j.bmcl.2016.05.038 10.1016/bs.mie.2016.01.020 |
ContentType | Journal Article |
Copyright | 2021 Elsevier B.V. Copyright © 2021 Elsevier B.V. All rights reserved. |
Copyright_xml | – notice: 2021 Elsevier B.V. – notice: Copyright © 2021 Elsevier B.V. All rights reserved. |
DBID | AAYXX CITATION 7X8 7S9 L.6 |
DOI | 10.1016/j.bbagen.2021.129990 |
DatabaseName | CrossRef MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
DatabaseTitle | CrossRef MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
DatabaseTitleList | MEDLINE - Academic AGRICOLA |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Chemistry Biology |
EISSN | 1872-8006 |
ExternalDocumentID | 10_1016_j_bbagen_2021_129990 S0304416521001495 |
GroupedDBID | --- --K --M .~1 0R~ 1B1 1RT 1~. 1~5 23N 3O- 4.4 457 4G. 53G 5GY 5RE 5VS 7-5 71M 8P~ 9JM AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AAXUO ABEFU ABFNM ABGSF ABMAC ABUDA ABXDB ABYKQ ACDAQ ACIUM ACRLP ADBBV ADEZE ADMUD ADUVX AEBSH AEHWI AEKER AFKWA AFTJW AFXIZ AGHFR AGRDE AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AJBFU AJOXV ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC CS3 DOVZS EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HLW HVGLF HZ~ IHE J1W KOM LX3 M41 MO0 N9A O-L O9- OAUVE OHT OZT P-8 P-9 PC. Q38 R2- ROL RPZ SBG SCC SDF SDG SDP SES SEW SPCBC SSU SSZ T5K UQL WH7 WUQ XJT XPP ~G- AAHBH AATTM AAXKI AAYWO AAYXX ABWVN ACRPL ACVFH ADCNI ADNMO AEIPS AEUPX AFJKZ AFPUW AGCQF AGQPQ AGRNS AIGII AIIUN AKBMS AKRWK AKYEP ANKPU APXCP BNPGV CITATION SSH 7X8 ACLOT EFKBS ~HD 7S9 L.6 |
ID | FETCH-LOGICAL-c372t-60f4f0bad21ce7c546d7e65dc95f5d6c7fe1595549eae1ae786089e93279f7a63 |
IEDL.DBID | AIKHN |
ISSN | 0304-4165 1872-8006 |
IngestDate | Sun Sep 28 02:33:04 EDT 2025 Sun Sep 28 08:40:48 EDT 2025 Tue Jul 01 00:22:15 EDT 2025 Thu Apr 24 22:54:42 EDT 2025 Fri Feb 23 02:46:07 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 11 |
Keywords | LSD1/ KDM1A SPC HOMO LUMO SPE HS DFT NPT LSD2 LSD1 MD MD simulations SWIRM ASM QM SP AOL Hirshfeld surface PSA MM KMTs FAD RMSF QM/MM RMSD MAO-B Allosteric inhibitor LBFGS MAO-A SASA KDMs |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c372t-60f4f0bad21ce7c546d7e65dc95f5d6c7fe1595549eae1ae786089e93279f7a63 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PQID | 2561490376 |
PQPubID | 23479 |
ParticipantIDs | proquest_miscellaneous_2636462896 proquest_miscellaneous_2561490376 crossref_citationtrail_10_1016_j_bbagen_2021_129990 crossref_primary_10_1016_j_bbagen_2021_129990 elsevier_sciencedirect_doi_10_1016_j_bbagen_2021_129990 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | November 2021 2021-11-00 20211101 |
PublicationDateYYYYMMDD | 2021-11-01 |
PublicationDate_xml | – month: 11 year: 2021 text: November 2021 |
PublicationDecade | 2020 |
PublicationTitle | Biochimica et biophysica acta. General subjects |
PublicationYear | 2021 |
Publisher | Elsevier B.V |
Publisher_xml | – name: Elsevier B.V |
References | Zheng, Duan, Ma, Xu, Zi, Lv, Wang, Ye, Zhu, Mobley, Zhu, Wang, Li, Wang, Zhao, Liu (bb0015) 2013; 56 Deb, Wingelhofer, Amaral, Maiques-Diaz, Chadwick, Spencer, Williams, Leong, Maes, Somervaille (bb0145) 2019; 34 Sorna, Theisen, Stephens, Warner, Bearss, Vankayalapati, Sharma (bb0110) 2013; 56 Wu, Zhou, Yao, Wei, Feng, Deng, Song (bb0095) 2016; 59 Ota, Itoh, Kaise, Ohta, Endo, Masuda, Sowa, Sakai, Suzuki (bb0085) 2016; 55 Fiskus, Sharma, Shah, Portier, Devaraj, Liu, Iyer, Bearss, Bhalla (bb0130) 2014; 28 Ma, Zheng, Wang, Wang, Wang, Pang, Zhang, Wang, Ding, Li, Wang, Hu, Liu, Zhang, Wang, Wang, Zhao, Liu (bb0050) 2015; 58 Wen, Chen, Zeng, Zhao, Li, Liu, Zhang (bb0080) 2012; 33 Jostes, Nettersheim, Schorle (bb0140) 2019; 16 Zheng, Ma, Wang, Li, Jiang, Zhou, Shi, Wang, Zhao, Liu (bb0005) 2015; 35 Suzuki, Miyata (bb0040) 2011; 54 Sehrawat, Gao, Wang, Bankhead, McWeeney, King, Schwartzman, Urrutia, Bisson, Coleman, Joshi, Kim, Sampson, Weinmann, Kallakury, Berry, Haque, Van Den Eeden, Sharma, Bearss, Beer, Thomas, Heiser, Alumkal (bb0175) 2018; 115 Sartori, Mercurio, Amigoni, Cappa, Faga, Fattori, Legnaghi, Ciossani, Mattevi, Meroni, Moretti, Cecatiello, Pasqualato, Romussi, Thaler, Trifiro, Villa, Vultaggio, Botrugno, Dessanti, Minucci, Zagarri, Carettoni, Iuzzolino, Varasi, Vianello (bb0100) 2017; 60 Magliulo, Bernardi, Messina (bb0070) 2018; 8 Vianello, Sartori, Amigoni, Cappa, Fagá, Fattori, Legnaghi, Ciossani, Mattevi, Meroni, Moretti, Cecatiello, Pasqualato, Romussi, Thaler, Trifiró, Varasi, Botrugno, Dessanti, Minucci, Vultaggio, Zagarrí, Varasi, Mercurio (bb0105) 2017; 60 Shivakumar, Williams, Wu, Damm, Shelley, Sherman (bb0180) 2010; 6 Zhou, Li, Wang, Xiang, Luo, Yang, Yang, Zhao (bb0120) 2016; 26 Kupcewicz, Malecka, Zapadka, Krajewska, Rozalski, Budzisz (bb0220) 2016; 26 Harancher, Packard, Cowan, DeLuca, Dembowski (bb0135) 2020; 94 Decarlo, Hadden (bb0030) 2012; 56 Hazeldine, Pachaiyappan, Steinbergs, Nowotarski, Hanson, Casero, Woster (bb0045) 2012; 55 Narayanan, Redfern, Assary, Curtiss (bb0200) 2019; 10 Vianello, Botrugno, Cappa, Dal Zuffo, Dessanti, Mai, Marrocco, Mattevi, Meroni, Minucci, Stazi, Thaler, Trifiró, Valente, Villa, Varasi, Mercurio (bb0010) 2016; 59 Li, Wang, Wang, Wang, Cheng (bb0185) 2015; 2015 Soldi, Ghosh Halder, Weston, Thode, Drenner, Lewis, Kaadige, Srivastava, Daniel Ampanattu, Rodriguez Del Villar, Lang, Vankayalapati, Weissman, Trent, Hendricks, Sharma (bb0155) 2020; 15 Hayward, Cole (bb0075) 2016; 573 Mould, Alli, Bremberg, Cartic, Jordan, Geitmann, Maiques-Diaz, McGonagle, Somervaille, Spencer, Turlais, Ogilvie (bb0055) 2017; 60 Wang, Liu, Jiang, Chen, Guo, Weng (bb0090) 2015; 47 Huang, Rauscher, Nawrocki, Ran, Feig, de Groot, Grubmuller, MacKerell (bb0170) 2017; 14 Stazi, Zwergel, Valente, Mai (bb0065) 2016; 26 Parvarinezhad, Salehi (bb0215) 2020; 1222 Wang, Gao, Song, Hu, Wang, Cheng (bb0190) 2019; 21 Rodrigues-Oliveira, Ribeiro, Cervi, Correra (bb0195) 2018; 3 Peng, Zhang, Tan, Li, Zhou, Wang, Liu, Li, Cen, Yang, Zhao (bb0125) 2020; 12 Wang, He, Li, Ma, Xue, Hu, Wang, Zhang, Zhang (bb0210) 2020; 193 Ma, Yao, Zheng, Feng, Chang, Yu, Liu (bb0020) 2019; 162 Romussi, Cappa, Vianello, Brambillasca, Cera, Dal Zuffo, Fagà, Fattori, Moretti, Trifirò, Villa, Vultaggio, Cecatiello, Pasqualato, Dondio, So, Minucci, Sartori, Varasi, Mercurio (bb0035) 2020; 11 Walker, Harvey, Sen, Dessent (bb0205) 2013; 117 Niwa, Sato, Hashimoto, Matsuno, Umehara (bb0060) 2018; 23 Baron, Vellore (bb0160) 2012; 51 Li, Wang, Xu, Huang, Li, Jin, Zhao, Cheng (bb0165) 2014; 9 Shi, Lan, Matson, Mulligan, Whetstine, Cole, Casero, Shi (bb0025) 2004; 119 Parwani (bb0225) 2009; 2009 Fang, Liao, Yu (bb0150) 2019; 12 Li, Tao, Zuo, Zhou, Qian, Lin, Jie, Liu, Li, Zhang, Zhang, Cen, Yang, Zhao (bb0115) 2019; 454 Ma (10.1016/j.bbagen.2021.129990_bb0020) 2019; 162 Vianello (10.1016/j.bbagen.2021.129990_bb0105) 2017; 60 Parvarinezhad (10.1016/j.bbagen.2021.129990_bb0215) 2020; 1222 Zhou (10.1016/j.bbagen.2021.129990_bb0120) 2016; 26 Fang (10.1016/j.bbagen.2021.129990_bb0150) 2019; 12 Niwa (10.1016/j.bbagen.2021.129990_bb0060) 2018; 23 Wen (10.1016/j.bbagen.2021.129990_bb0080) 2012; 33 Narayanan (10.1016/j.bbagen.2021.129990_bb0200) 2019; 10 Baron (10.1016/j.bbagen.2021.129990_bb0160) 2012; 51 Wang (10.1016/j.bbagen.2021.129990_bb0190) 2019; 21 Walker (10.1016/j.bbagen.2021.129990_bb0205) 2013; 117 Li (10.1016/j.bbagen.2021.129990_bb0185) 2015; 2015 Wang (10.1016/j.bbagen.2021.129990_bb0090) 2015; 47 Mould (10.1016/j.bbagen.2021.129990_bb0055) 2017; 60 Li (10.1016/j.bbagen.2021.129990_bb0115) 2019; 454 Deb (10.1016/j.bbagen.2021.129990_bb0145) 2019; 34 Sorna (10.1016/j.bbagen.2021.129990_bb0110) 2013; 56 Peng (10.1016/j.bbagen.2021.129990_bb0125) 2020; 12 Zheng (10.1016/j.bbagen.2021.129990_bb0005) 2015; 35 Rodrigues-Oliveira (10.1016/j.bbagen.2021.129990_bb0195) 2018; 3 Hayward (10.1016/j.bbagen.2021.129990_bb0075) 2016; 573 Harancher (10.1016/j.bbagen.2021.129990_bb0135) 2020; 94 Decarlo (10.1016/j.bbagen.2021.129990_bb0030) 2012; 56 Wu (10.1016/j.bbagen.2021.129990_bb0095) 2016; 59 Shivakumar (10.1016/j.bbagen.2021.129990_bb0180) 2010; 6 Suzuki (10.1016/j.bbagen.2021.129990_bb0040) 2011; 54 Jostes (10.1016/j.bbagen.2021.129990_bb0140) 2019; 16 Sehrawat (10.1016/j.bbagen.2021.129990_bb0175) 2018; 115 Vianello (10.1016/j.bbagen.2021.129990_bb0010) 2016; 59 Zheng (10.1016/j.bbagen.2021.129990_bb0015) 2013; 56 Parwani (10.1016/j.bbagen.2021.129990_bb0225) 2009; 2009 Sartori (10.1016/j.bbagen.2021.129990_bb0100) 2017; 60 Stazi (10.1016/j.bbagen.2021.129990_bb0065) 2016; 26 Li (10.1016/j.bbagen.2021.129990_bb0165) 2014; 9 Romussi (10.1016/j.bbagen.2021.129990_bb0035) 2020; 11 Fiskus (10.1016/j.bbagen.2021.129990_bb0130) 2014; 28 Hazeldine (10.1016/j.bbagen.2021.129990_bb0045) 2012; 55 Huang (10.1016/j.bbagen.2021.129990_bb0170) 2017; 14 Soldi (10.1016/j.bbagen.2021.129990_bb0155) 2020; 15 Wang (10.1016/j.bbagen.2021.129990_bb0210) 2020; 193 Kupcewicz (10.1016/j.bbagen.2021.129990_bb0220) 2016; 26 Shi (10.1016/j.bbagen.2021.129990_bb0025) 2004; 119 Ma (10.1016/j.bbagen.2021.129990_bb0050) 2015; 58 Magliulo (10.1016/j.bbagen.2021.129990_bb0070) 2018; 8 Ota (10.1016/j.bbagen.2021.129990_bb0085) 2016; 55 |
References_xml | – volume: 117 start-page: 12590 year: 2013 end-page: 12600 ident: bb0205 article-title: Performance of M06, M06–2X, and M06-HF density functionals for conformationally flexible anionic clusters: M06 functionals perform better than B3LYP for a model system with dispersion and ionic hydrogen-bonding interactions publication-title: J. Phys. Chem. A – volume: 6 start-page: 1509 year: 2010 end-page: 1519 ident: bb0180 article-title: Prediction of absolute solvation free energies using molecular dynamics free energy perturbation and the OPLS force field publication-title: J. Chem. Theory Comput. – volume: 58 start-page: 1705 year: 2015 end-page: 1716 ident: bb0050 article-title: Design, synthesis, and structure-activity relationship of novel LSD1 inhibitors based on pyrimidine-thiourea hybrids as potent, orally active antitumor agents publication-title: J. Med. Chem. – volume: 28 start-page: 2155 year: 2014 end-page: 2164 ident: bb0130 article-title: Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells publication-title: Leukemia – volume: 10 start-page: 7449 year: 2019 end-page: 7455 ident: bb0200 article-title: Accurate quantum chemical energies for 133 000 organic molecules publication-title: Chem. Sci. – volume: 14 start-page: 71 year: 2017 end-page: 73 ident: bb0170 article-title: CHARMM36m: an improved force field for folded and intrinsically disordered proteins publication-title: Nat. Methods – volume: 59 start-page: 1501 year: 2016 end-page: 1517 ident: bb0010 article-title: Discovery of a novel inhibitor of histone lysine-specific demethylase 1A (KDM1A/LSD1) as orally active antitumor agent publication-title: J. Med. Chem. – volume: 54 start-page: 8236 year: 2011 end-page: 8250 ident: bb0040 article-title: Lysine demethylases inhibitors publication-title: J. Med. Chem. – volume: 11 start-page: 754 year: 2020 end-page: 759 ident: bb0035 article-title: Discovery of reversible inhibitors of KDM1A efficacious in acute myeloid leukemia models publication-title: ACS Med. Chem. Lett. – volume: 454 start-page: 179 year: 2019 end-page: 190 ident: bb0115 article-title: ZY0511, a novel, potent and selective LSD1 inhibitor, exhibits anticancer activity against solid tumors via the DDIT4/mTOR pathway publication-title: Cancer Lett. – volume: 60 start-page: 1693 year: 2017 end-page: 1715 ident: bb0105 publication-title: J. Med. Chem. – volume: 47 start-page: 485 year: 2015 end-page: 490 ident: bb0090 article-title: Relationship between LSD1 expression and E-cadherin expression in prostate cancer publication-title: Int. Urol. Nephrol. – volume: 34 start-page: 1266 year: 2019 end-page: 1277 ident: bb0145 article-title: Pre-clinical activity of combined LSD1 and mTORC1 inhibition in MLL-translocated acute myeloid leukaemia publication-title: Leukemia – volume: 115 start-page: E4179 year: 2018 end-page: E4188 ident: bb0175 article-title: LSD1 activates a lethal prostate cancer gene network independently of its demethylase function publication-title: Proc. Natl. Acad. Sci. U. S. A. – volume: 573 start-page: 261 year: 2016 end-page: 278 ident: bb0075 article-title: LSD1 histone demethylase assays and inhibition publication-title: Methods Enzymol. – volume: 2015 year: 2015 ident: bb0185 article-title: In silico design of human IMPDH inhibitors using pharmacophore mapping and molecular docking approaches publication-title: Comput. Math. Method. M. – volume: 8 start-page: 255 year: 2018 ident: bb0070 article-title: Lysine-specific demethylase 1A as a promising target in acute myeloid leukemia publication-title: Front. Oncol. – volume: 1222 year: 2020 ident: bb0215 article-title: Synthesis, characterization, crystal structures, Hirshfeld surface analysis and DFT computational studies of new Schiff bases derived from phenylhydrazine publication-title: J. Mol. Struct. – volume: 23 year: 2018 ident: bb0060 article-title: Crystal structure of LSD1 in complex with 4-[5-(piperidin-4-ylmethoxy)-2-(p-tolyl)pyridin-3-yl]benzonitrile publication-title: Molecules – volume: 33 start-page: 109 year: 2012 end-page: 119 ident: bb0080 article-title: Triptolide induces cell-cycle arrest and apoptosis of human multiple myeloma cells in vitro via altering expression of histone demethylase LSD1 and JMJD2B publication-title: Acta Pharmacol. Sin. – volume: 15 year: 2020 ident: bb0155 article-title: The novel reversible LSD1 inhibitor SP-2577 promotes anti-tumor immunity in SWItch/Sucrose-NonFermentable (SWI/SNF) complex mutated ovarian cancer publication-title: Plos One – volume: 35 start-page: 1032 year: 2015 end-page: 1071 ident: bb0005 article-title: A systematic review of histone lysine-specific demethylase 1 and its inhibitors publication-title: Med. Res. Rev. – volume: 26 start-page: 4552 year: 2016 end-page: 4557 ident: bb0120 article-title: Synthesis and biological evaluation of novel (E)-N'-(2,3-dihydro-1H-inden-1-ylidene) benzohydrazides as potent LSD1 inhibitors publication-title: Bioorg. Med. Chem. Lett. – volume: 59 start-page: 253 year: 2016 end-page: 263 ident: bb0095 article-title: 3-(Piperidin-4-ylmethoxy)pyridine containing compounds are potent inhibitors of lysine specific demethylase 1 publication-title: J. Med. Chem. – volume: 193 year: 2020 ident: bb0210 article-title: Carvedilol serves as a novel CYP1B1 inhibitor, a systematic drug repurposing approach through structure-based virtual screening and experimental verification publication-title: Eur. J. Med. Chem. – volume: 162 start-page: 555 year: 2019 end-page: 567 ident: bb0020 article-title: Ligand-based design, synthesis and biological evaluation of xanthine derivatives as LSD1/KDM1A inhibitors publication-title: Eur. J. Med. Chem. – volume: 55 start-page: 7378 year: 2012 end-page: 7391 ident: bb0045 article-title: Low molecular weight amidoximes that act as potent inhibitors of lysine-specific demethylase 1 publication-title: J. Med. Chem. – volume: 55 start-page: 16115 year: 2016 end-page: 16118 ident: bb0085 article-title: Targeting cancer with PCPA-drug conjugates: LSD1 inhibition-triggered release of 4-hydroxytamoxifen publication-title: Angew. Chem. Int. Ed. Engl. – volume: 26 start-page: 3336 year: 2016 end-page: 3341 ident: bb0220 article-title: Quantitative relationships between structure and cytotoxic activity of flavonoid derivatives. an application of Hirshfeld surface derived descriptors publication-title: Bioorg. Med. Chem. Lett. – volume: 60 start-page: 7984 year: 2017 end-page: 7999 ident: bb0055 article-title: Development of (4-cyanophenyl)glycine derivatives as reversible inhibitors of lysine specific demethylase 1 publication-title: J. Med. Chem. – volume: 26 start-page: 565 year: 2016 end-page: 580 ident: bb0065 article-title: LSD1 inhibitors: a patent review (2010–2015) publication-title: Expert. Opin. Ther. Pat. – volume: 56 start-page: 9496 year: 2013 end-page: 9508 ident: bb0110 article-title: High-throughput virtual screening identifies novel N'-(1-phenylethylidene)-benzohydrazides as potent, specific, and reversible LSD1 inhibitors publication-title: J. Med. Chem. – volume: 21 start-page: 24147 year: 2019 end-page: 24164 ident: bb0190 article-title: Molecular dynamics simulation and QM/MM calculation reveal the selectivity mechanism of type I 1/2 kinase inhibitors: the effect of intramolecular H-bonds and conformational restriction for improved selectivity publication-title: Phys. Chem. Chem. Phys. – volume: 12 start-page: 129 year: 2019 ident: bb0150 article-title: LSD1/KDM1A inhibitors in clinical trials: advances and prospects publication-title: J. Hematol. Oncol. – volume: 56 start-page: 8543 year: 2013 end-page: 8560 ident: bb0015 article-title: Triazole-dithiocarbamate based selective lysine specific demethylase 1 (LSD1) inactivators inhibit gastric cancer cell growth, invasion, and migration publication-title: J. Med. Chem. – volume: 60 start-page: 1673 year: 2017 end-page: 1692 ident: bb0100 article-title: Thieno[3,2-b]pyrrole-5-carboxamides as new reversible inhibitors of histone lysine demethylase KDM1A/LSD1. part 1: high-throughput screening and preliminary exploration publication-title: J. Med. Chem. – volume: 94 year: 2020 ident: bb0135 article-title: Antiviral properties of the LSD1 inhibitor SP-2509 publication-title: J. Virol. – volume: 9 start-page: 1012 year: 2014 end-page: 1022 ident: bb0165 article-title: Computational insight into p21-activated kinase 4 inhibition: a combined ligand- and structure-based approach publication-title: ChemMedChem – volume: 2009 start-page: 93 year: 2009 end-page: 95 ident: bb0225 publication-title: Expression of Glypican 3 in Ovarian and Extragonadal Germ Cell Tumors, Yearbook of Pathology and Laboratory Medicine – volume: 56 start-page: 179 year: 2012 end-page: 194 ident: bb0030 article-title: Oncoepigenomics: making histone lysine methylation count publication-title: Eur. J. Med. Chem. – volume: 3 start-page: 9075 year: 2018 end-page: 9085 ident: bb0195 article-title: Evaluation of common theoretical methods for predicting infrared multiphotonic dissociation vibrational spectra of intramolecular hydrogen-bonded ions publication-title: ACS Omega – volume: 119 start-page: 941 year: 2004 end-page: 953 ident: bb0025 article-title: Histone demethylation mediated by the nuclear amine oxidase homolog LSD1 publication-title: Cell – volume: 16 start-page: 245 year: 2019 end-page: 259 ident: bb0140 article-title: Epigenetic drugs and their molecular targets in testicular germ cell tumours publication-title: Nat. Rev. Urol. – volume: 12 year: 2020 ident: bb0125 article-title: Synergistic antitumor effect of 5-fluorouracil with the novel LSD1 inhibitor ZY0511 in colorectal cancer publication-title: Ther. Adv. Med. Oncol. – volume: 51 start-page: 3151 year: 2012 end-page: 3153 ident: bb0160 article-title: LSD1/CoREST reversible opening-closing dynamics: discovery of a nanoscale clamp for chromatin and protein binding publication-title: Biochemistry – volume: 47 start-page: 485 year: 2015 ident: 10.1016/j.bbagen.2021.129990_bb0090 article-title: Relationship between LSD1 expression and E-cadherin expression in prostate cancer publication-title: Int. Urol. Nephrol. doi: 10.1007/s11255-015-0915-2 – volume: 60 start-page: 7984 year: 2017 ident: 10.1016/j.bbagen.2021.129990_bb0055 article-title: Development of (4-cyanophenyl)glycine derivatives as reversible inhibitors of lysine specific demethylase 1 publication-title: J. Med. Chem. doi: 10.1021/acs.jmedchem.7b00462 – volume: 16 start-page: 245 year: 2019 ident: 10.1016/j.bbagen.2021.129990_bb0140 article-title: Epigenetic drugs and their molecular targets in testicular germ cell tumours publication-title: Nat. Rev. Urol. doi: 10.1038/s41585-019-0154-x – volume: 1222 year: 2020 ident: 10.1016/j.bbagen.2021.129990_bb0215 article-title: Synthesis, characterization, crystal structures, Hirshfeld surface analysis and DFT computational studies of new Schiff bases derived from phenylhydrazine publication-title: J. Mol. Struct. doi: 10.1016/j.molstruc.2020.128780 – volume: 23 year: 2018 ident: 10.1016/j.bbagen.2021.129990_bb0060 article-title: Crystal structure of LSD1 in complex with 4-[5-(piperidin-4-ylmethoxy)-2-(p-tolyl)pyridin-3-yl]benzonitrile publication-title: Molecules doi: 10.3390/molecules23071538 – volume: 454 start-page: 179 year: 2019 ident: 10.1016/j.bbagen.2021.129990_bb0115 article-title: ZY0511, a novel, potent and selective LSD1 inhibitor, exhibits anticancer activity against solid tumors via the DDIT4/mTOR pathway publication-title: Cancer Lett. doi: 10.1016/j.canlet.2019.03.052 – volume: 33 start-page: 109 year: 2012 ident: 10.1016/j.bbagen.2021.129990_bb0080 article-title: Triptolide induces cell-cycle arrest and apoptosis of human multiple myeloma cells in vitro via altering expression of histone demethylase LSD1 and JMJD2B publication-title: Acta Pharmacol. Sin. doi: 10.1038/aps.2011.145 – volume: 59 start-page: 253 year: 2016 ident: 10.1016/j.bbagen.2021.129990_bb0095 article-title: 3-(Piperidin-4-ylmethoxy)pyridine containing compounds are potent inhibitors of lysine specific demethylase 1 publication-title: J. Med. Chem. doi: 10.1021/acs.jmedchem.5b01361 – volume: 193 year: 2020 ident: 10.1016/j.bbagen.2021.129990_bb0210 article-title: Carvedilol serves as a novel CYP1B1 inhibitor, a systematic drug repurposing approach through structure-based virtual screening and experimental verification publication-title: Eur. J. Med. Chem. doi: 10.1016/j.ejmech.2020.112235 – volume: 55 start-page: 7378 year: 2012 ident: 10.1016/j.bbagen.2021.129990_bb0045 article-title: Low molecular weight amidoximes that act as potent inhibitors of lysine-specific demethylase 1 publication-title: J. Med. Chem. doi: 10.1021/jm3002845 – volume: 15 year: 2020 ident: 10.1016/j.bbagen.2021.129990_bb0155 article-title: The novel reversible LSD1 inhibitor SP-2577 promotes anti-tumor immunity in SWItch/Sucrose-NonFermentable (SWI/SNF) complex mutated ovarian cancer publication-title: Plos One doi: 10.1371/journal.pone.0235705 – volume: 60 start-page: 1673 year: 2017 ident: 10.1016/j.bbagen.2021.129990_bb0100 article-title: Thieno[3,2-b]pyrrole-5-carboxamides as new reversible inhibitors of histone lysine demethylase KDM1A/LSD1. part 1: high-throughput screening and preliminary exploration publication-title: J. Med. Chem. doi: 10.1021/acs.jmedchem.6b01018 – volume: 59 start-page: 1501 year: 2016 ident: 10.1016/j.bbagen.2021.129990_bb0010 article-title: Discovery of a novel inhibitor of histone lysine-specific demethylase 1A (KDM1A/LSD1) as orally active antitumor agent publication-title: J. Med. Chem. doi: 10.1021/acs.jmedchem.5b01209 – volume: 58 start-page: 1705 year: 2015 ident: 10.1016/j.bbagen.2021.129990_bb0050 article-title: Design, synthesis, and structure-activity relationship of novel LSD1 inhibitors based on pyrimidine-thiourea hybrids as potent, orally active antitumor agents publication-title: J. Med. Chem. doi: 10.1021/acs.jmedchem.5b00037 – volume: 11 start-page: 754 year: 2020 ident: 10.1016/j.bbagen.2021.129990_bb0035 article-title: Discovery of reversible inhibitors of KDM1A efficacious in acute myeloid leukemia models publication-title: ACS Med. Chem. Lett. doi: 10.1021/acsmedchemlett.9b00604 – volume: 14 start-page: 71 year: 2017 ident: 10.1016/j.bbagen.2021.129990_bb0170 article-title: CHARMM36m: an improved force field for folded and intrinsically disordered proteins publication-title: Nat. Methods doi: 10.1038/nmeth.4067 – volume: 60 start-page: 1693 year: 2017 ident: 10.1016/j.bbagen.2021.129990_bb0105 publication-title: J. Med. Chem. doi: 10.1021/acs.jmedchem.6b01019 – volume: 10 start-page: 7449 year: 2019 ident: 10.1016/j.bbagen.2021.129990_bb0200 article-title: Accurate quantum chemical energies for 133 000 organic molecules publication-title: Chem. Sci. doi: 10.1039/C9SC02834J – volume: 119 start-page: 941 year: 2004 ident: 10.1016/j.bbagen.2021.129990_bb0025 article-title: Histone demethylation mediated by the nuclear amine oxidase homolog LSD1 publication-title: Cell doi: 10.1016/j.cell.2004.12.012 – volume: 28 start-page: 2155 year: 2014 ident: 10.1016/j.bbagen.2021.129990_bb0130 article-title: Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells publication-title: Leukemia doi: 10.1038/leu.2014.119 – volume: 94 year: 2020 ident: 10.1016/j.bbagen.2021.129990_bb0135 article-title: Antiviral properties of the LSD1 inhibitor SP-2509 publication-title: J. Virol. doi: 10.1128/JVI.00974-20 – volume: 21 start-page: 24147 year: 2019 ident: 10.1016/j.bbagen.2021.129990_bb0190 article-title: Molecular dynamics simulation and QM/MM calculation reveal the selectivity mechanism of type I 1/2 kinase inhibitors: the effect of intramolecular H-bonds and conformational restriction for improved selectivity publication-title: Phys. Chem. Chem. Phys. doi: 10.1039/C9CP04353E – volume: 56 start-page: 9496 year: 2013 ident: 10.1016/j.bbagen.2021.129990_bb0110 article-title: High-throughput virtual screening identifies novel N'-(1-phenylethylidene)-benzohydrazides as potent, specific, and reversible LSD1 inhibitors publication-title: J. Med. Chem. doi: 10.1021/jm400870h – volume: 3 start-page: 9075 year: 2018 ident: 10.1016/j.bbagen.2021.129990_bb0195 article-title: Evaluation of common theoretical methods for predicting infrared multiphotonic dissociation vibrational spectra of intramolecular hydrogen-bonded ions publication-title: ACS Omega doi: 10.1021/acsomega.8b00815 – volume: 117 start-page: 12590 year: 2013 ident: 10.1016/j.bbagen.2021.129990_bb0205 article-title: Performance of M06, M06–2X, and M06-HF density functionals for conformationally flexible anionic clusters: M06 functionals perform better than B3LYP for a model system with dispersion and ionic hydrogen-bonding interactions publication-title: J. Phys. Chem. A doi: 10.1021/jp408166m – volume: 54 start-page: 8236 year: 2011 ident: 10.1016/j.bbagen.2021.129990_bb0040 article-title: Lysine demethylases inhibitors publication-title: J. Med. Chem. doi: 10.1021/jm201048w – volume: 34 start-page: 1266 year: 2019 ident: 10.1016/j.bbagen.2021.129990_bb0145 article-title: Pre-clinical activity of combined LSD1 and mTORC1 inhibition in MLL-translocated acute myeloid leukaemia publication-title: Leukemia doi: 10.1038/s41375-019-0659-6 – volume: 51 start-page: 3151 year: 2012 ident: 10.1016/j.bbagen.2021.129990_bb0160 article-title: LSD1/CoREST reversible opening-closing dynamics: discovery of a nanoscale clamp for chromatin and protein binding publication-title: Biochemistry doi: 10.1021/bi300068r – volume: 115 start-page: E4179 year: 2018 ident: 10.1016/j.bbagen.2021.129990_bb0175 article-title: LSD1 activates a lethal prostate cancer gene network independently of its demethylase function publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.1719168115 – volume: 8 start-page: 255 year: 2018 ident: 10.1016/j.bbagen.2021.129990_bb0070 article-title: Lysine-specific demethylase 1A as a promising target in acute myeloid leukemia publication-title: Front. Oncol. doi: 10.3389/fonc.2018.00255 – volume: 12 start-page: 129 year: 2019 ident: 10.1016/j.bbagen.2021.129990_bb0150 article-title: LSD1/KDM1A inhibitors in clinical trials: advances and prospects publication-title: J. Hematol. Oncol. doi: 10.1186/s13045-019-0811-9 – volume: 55 start-page: 16115 year: 2016 ident: 10.1016/j.bbagen.2021.129990_bb0085 article-title: Targeting cancer with PCPA-drug conjugates: LSD1 inhibition-triggered release of 4-hydroxytamoxifen publication-title: Angew. Chem. Int. Ed. Engl. doi: 10.1002/anie.201608711 – volume: 56 start-page: 179 year: 2012 ident: 10.1016/j.bbagen.2021.129990_bb0030 article-title: Oncoepigenomics: making histone lysine methylation count publication-title: Eur. J. Med. Chem. doi: 10.1016/j.ejmech.2012.08.010 – volume: 2015 year: 2015 ident: 10.1016/j.bbagen.2021.129990_bb0185 article-title: In silico design of human IMPDH inhibitors using pharmacophore mapping and molecular docking approaches publication-title: Comput. Math. Method. M. – volume: 26 start-page: 565 year: 2016 ident: 10.1016/j.bbagen.2021.129990_bb0065 article-title: LSD1 inhibitors: a patent review (2010–2015) publication-title: Expert. Opin. Ther. Pat. doi: 10.1517/13543776.2016.1165209 – volume: 162 start-page: 555 year: 2019 ident: 10.1016/j.bbagen.2021.129990_bb0020 article-title: Ligand-based design, synthesis and biological evaluation of xanthine derivatives as LSD1/KDM1A inhibitors publication-title: Eur. J. Med. Chem. doi: 10.1016/j.ejmech.2018.11.035 – volume: 6 start-page: 1509 year: 2010 ident: 10.1016/j.bbagen.2021.129990_bb0180 article-title: Prediction of absolute solvation free energies using molecular dynamics free energy perturbation and the OPLS force field publication-title: J. Chem. Theory Comput. doi: 10.1021/ct900587b – volume: 2009 start-page: 93 year: 2009 ident: 10.1016/j.bbagen.2021.129990_bb0225 – volume: 12 year: 2020 ident: 10.1016/j.bbagen.2021.129990_bb0125 article-title: Synergistic antitumor effect of 5-fluorouracil with the novel LSD1 inhibitor ZY0511 in colorectal cancer publication-title: Ther. Adv. Med. Oncol. doi: 10.1177/1758835920937428 – volume: 56 start-page: 8543 year: 2013 ident: 10.1016/j.bbagen.2021.129990_bb0015 article-title: Triazole-dithiocarbamate based selective lysine specific demethylase 1 (LSD1) inactivators inhibit gastric cancer cell growth, invasion, and migration publication-title: J. Med. Chem. doi: 10.1021/jm401002r – volume: 9 start-page: 1012 year: 2014 ident: 10.1016/j.bbagen.2021.129990_bb0165 article-title: Computational insight into p21-activated kinase 4 inhibition: a combined ligand- and structure-based approach publication-title: ChemMedChem doi: 10.1002/cmdc.201400016 – volume: 26 start-page: 4552 year: 2016 ident: 10.1016/j.bbagen.2021.129990_bb0120 article-title: Synthesis and biological evaluation of novel (E)-N'-(2,3-dihydro-1H-inden-1-ylidene) benzohydrazides as potent LSD1 inhibitors publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/j.bmcl.2015.06.054 – volume: 35 start-page: 1032 year: 2015 ident: 10.1016/j.bbagen.2021.129990_bb0005 article-title: A systematic review of histone lysine-specific demethylase 1 and its inhibitors publication-title: Med. Res. Rev. doi: 10.1002/med.21350 – volume: 26 start-page: 3336 year: 2016 ident: 10.1016/j.bbagen.2021.129990_bb0220 article-title: Quantitative relationships between structure and cytotoxic activity of flavonoid derivatives. an application of Hirshfeld surface derived descriptors publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/j.bmcl.2016.05.038 – volume: 573 start-page: 261 year: 2016 ident: 10.1016/j.bbagen.2021.129990_bb0075 article-title: LSD1 histone demethylase assays and inhibition publication-title: Methods Enzymol. doi: 10.1016/bs.mie.2016.01.020 |
SSID | ssj0000595 |
Score | 2.4038615 |
Snippet | Histone lysine-specific demethylase 1 (LSD1) has become a potential anticancer target for the novel drug discovery. Recent reports have shown that SP2509 and... |
SourceID | proquest crossref elsevier |
SourceType | Aggregation Database Enrichment Source Index Database Publisher |
StartPage | 129990 |
SubjectTerms | Allosteric inhibitor chlorine drugs geometry Hirshfeld surface histones ligands LSD1 MD simulations molecular dynamics pharmacology QM/MM quantum mechanics surface area |
Title | Intermolecular insights into allosteric inhibition of histone lysine-specific demethylase 1 |
URI | https://dx.doi.org/10.1016/j.bbagen.2021.129990 https://www.proquest.com/docview/2561490376 https://www.proquest.com/docview/2636462896 |
Volume | 1865 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NS-UwEB_0yaIX8Wvxmwh7ja-fSXuUh_JU9KKC4CEkaYJddvvE9zx48W93Jm2VlUXBW1MSWibpzC_NzO8H8KvUOjZF4XlssohnaVJxjIoFlxXuHXRqMhlE-y4uxfgmO7vNb-dg1NfCUFpl5_tbnx68dXdn2Flz-FDXwys61EM4gfGnxfnzsJBgtC8GsHB0ej6-fHfIeRBfof6cBvQVdCHNyxj8bokINYkPMfYF5_z_CPXBV4cAdLICyx1yZEfty63CnGvW4EerJfm8BoujXrptHe7Cf76_vfItq5sp7cGneDGbMDpqJ3qE2mL7vjYhaYtNPAvcw41jxFLSOE5FmJRIxCpHOtPPiLMdizfg5uT4ejTmnYoCt6lMZlxEPvOR0VUSWydtnolKOpFXtsx9XgkrvUNIg6iidNrF2slCREXpENfJ0kst0p8waPDhm8CE99qK1FYIgjJtc-11nHoEFF6YSPhkC9Lecsp2FOOkdPFH9blkv1Vrb0X2Vq29t4C_jXpoKTa-6C_7SVH_LBWFUeCLkQf9HCqcEToa0Y2bPE1VQoSoZYTe9pM-IhVUyVuK7W-_wQ4sUastZtyFwezxye0hqpmZfZg_fIn3u7X7Ckod90I |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB7RXVVwQZRS8WyNxNXdPO3kuFoVLQX2UpCQerBsxxZBkEXscuDfM-MkVKCqSL3lYSvWOJn5HM98H8BRqXVsisLz2GQRz9Kk4hgVCy4rXDvo1GQyiPadz8T0Mvt5lV-twKSvhaG0ys73tz49eOvuyqiz5ui-rke_aFMP4QTGnxbnf4BhRqLWAxiOT06nsz8OOQ_iK9SeU4e-gi6keRmD3y0RoSbxd4x9wTn_PUK98dUhAB1vwHqHHNm4HdwnWHHNJnxstSSfNmF10ku3fYbf4T_fXa98y-pmQWvwBR4s54y22okeobZ4fl2bkLTF5p4F7uHGMWIpaRynIkxKJGKVI53pJ8TZjsVbcHn842Iy5Z2KArepTJZcRD7zkdFVElsnbZ6JSjqRV7bMfV4JK71DSIOoonTaxdrJQkRF6RDXydJLLdIvMGjw4dvAhPfaitRWCIIybXPtdZx6BBRemEj4ZAfS3nLKdhTjpHRxq_pcshvV2luRvVVr7x3gL73uW4qNd9rLflLUq1dFYRR4p-dhP4cKZ4S2RnTj5o8LlRAhahmht_1HG5EKquQtxe5_j-AbrE4vzs_U2cnsdA_W6E5b2LgPg-XDoztAhLM0X7s3-Bked_ko |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Intermolecular+insights+into+allosteric+inhibition+of+histone+lysine-specific+demethylase+1&rft.jtitle=Biochimica+et+biophysica+acta.+General+subjects&rft.au=Zhang%2C+Xiangyu&rft.au=Sun%2C+Yixiang&rft.au=Zhang%2C+Ziheng&rft.au=Wang%2C+Hanxun&rft.date=2021-11-01&rft.issn=0304-4165&rft.volume=1865&rft.issue=11&rft.spage=129990&rft_id=info:doi/10.1016%2Fj.bbagen.2021.129990&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_bbagen_2021_129990 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0304-4165&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0304-4165&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0304-4165&client=summon |